Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
10/29/2008 | EP1985635A1 Process for producing polysaccharide from coffee bean or/and coffee extraction residue |
10/29/2008 | EP1985297A1 Carboxylic acid compound and use thereof |
10/29/2008 | EP1985283A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier |
10/29/2008 | EP1984395A2 Modulation of bone formation |
10/29/2008 | EP1984329A2 Vitamin d analog - rak, methods and uses thereof |
10/29/2008 | EP1984028A2 Aqueous pharmaceutical formulations of er selective ligands |
10/29/2008 | EP1984024A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
10/29/2008 | EP1984016A1 Use of insulin-like factor 3 for treating osteoporosis and bone disorders |
10/29/2008 | EP1861100B1 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
10/29/2008 | EP1753764B1 Pyrrolopyridine derivatives |
10/29/2008 | EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy |
10/29/2008 | EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease |
10/29/2008 | EP1222208B1 Polypeptide derivatives of parathyroid hormone (pth) |
10/29/2008 | CN101296916A Dihydroxyanthraquinones and their use |
10/29/2008 | CN101296707A Method for prevention and/or treatment of rheumatoid arthritis |
10/29/2008 | CN101294187A Method for sustained-releasing polypeptide with biological activity and application thereof |
10/29/2008 | CN101293916A Monoclone antibody with combined function epiposition, specificity of osteopontin and uses thereof |
10/29/2008 | CN101293894A 2-propylidene-19-nor-vitamin D compounds |
10/29/2008 | CN101293888A Xanthine derivative, production and use thereof as a medicament |
10/29/2008 | CN101293087A Externally used Chinese medicinal composition for treating orthopedic disorders |
10/29/2008 | CN101293082A Anti-heart failure pharmaceutical composition for improving skeletal muscle function and preparation method thereof |
10/29/2008 | CN101293061A Plaster for promoting the reunion of fractured bones and preparing method thereof |
10/29/2008 | CN101293042A Medicament for treating necrosis of femoral head |
10/29/2008 | CN101293041A Externally used medicament for treating protrusion of lumbar vertebral disc, spinal canal stenosis |
10/29/2008 | CN101293033A Combined heating Chinese medicine cotton-padded mattress for treating lumbar diseases |
10/29/2008 | CN101293031A Compound preparation for treating cervical vertebra diseases and preparation technique |
10/29/2008 | CN101293030A Medicine liqueur for treating muscles and bones diseases |
10/29/2008 | CN101293013A Pharmaceutical composition for treating paralysis, preparation technique and quality testing method |
10/29/2008 | CN101292977A Pharmaceutical combination with stable strontium ranelate and its preparations |
10/29/2008 | CN101292975A Application of paclitaxel and its derivative in pharmacy |
10/29/2008 | CN100429232C Vaughan Tristan J. |
10/29/2008 | CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
10/29/2008 | CN100429201C Heterocyclic compounds and methods of use thereof |
10/29/2008 | CN100428959C Process for producing drug ultramicroparticle and apparatus therefor |
10/28/2008 | US7442790 Caspase inhibitors and uses thereof |
10/28/2008 | US7442763 Kidney diseases |
10/28/2008 | US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
10/28/2008 | US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia |
10/28/2008 | US7442704 Amide derivatives |
10/28/2008 | US7442703 Piperidine derivatives useful as CCR5 antagonists |
10/28/2008 | US7442702 Prostaglandin agonists |
10/28/2008 | US7442700 N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1f][1,2,4]triazin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent; allergies and asthma, Alzheimer's disease, rheumatoid arthritis, autoimmune diseases, bone diseases, inflammation |
10/28/2008 | US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide |
10/28/2008 | US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity |
10/28/2008 | US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation |
10/28/2008 | US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies |
10/28/2008 | CA2472107C Dibenzodiazepine derivates, their preparation and use |
10/28/2008 | CA2442227C Ccr5 antagonists useful for treating aids |
10/28/2008 | CA2433765C Use of botulinum toxin for treatment of articular pathologies |
10/28/2008 | CA2200568C Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
10/23/2008 | WO2008127727A1 Biaryl compositions and methods for modulating a kinase cascade |
10/23/2008 | WO2008127605A1 Pharmaceutical compositions comprising calcitonin and an aromatase inhibitor |
10/23/2008 | WO2008126940A1 Novel t cell |
10/23/2008 | WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same |
10/23/2008 | WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes |
10/23/2008 | WO2008126898A1 (aza)indole derivative and use thereof for medical purposes |
10/23/2008 | WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient |
10/23/2008 | WO2008126732A1 Fused bicyclic heteroaryl derivatives |
10/23/2008 | WO2008125724A1 Estimation and biological consequences of oxidative metabolism |
10/23/2008 | WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof |
10/23/2008 | WO2008124907A2 Resveratrol-containing composition for modulating bone formation |
10/23/2008 | WO2008061720A3 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders |
10/23/2008 | WO2008041118A3 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
10/23/2008 | WO2008006607A3 Pharmaceutical and nutraceutical products comprising vitamin k2 |
10/23/2008 | US20080262068 Method of Tonic Treatment With Oxyphenbutazone Derivatives |
10/23/2008 | US20080262065 Novel inhibitors of glutaminyl cyclases |
10/23/2008 | US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
10/23/2008 | US20080262041 Beta-Lactams for Treatment of Cns Disorders |
10/23/2008 | US20080262037 Piperidine Derivatives for the Treatment of Chemokine Mediated Disease |
10/23/2008 | US20080262016 Isoquinoline derivatives and methods of use thereof |
10/23/2008 | US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
10/23/2008 | US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
10/23/2008 | US20080261971 Novel Heterocyclic Nf-Kb Inhibitors |
10/23/2008 | US20080261968 Heterobicyclic metalloprotease inhibitors |
10/23/2008 | US20080261961 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases |
10/23/2008 | US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
10/23/2008 | US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
10/23/2008 | US20080261926 Pharmaceutical Calcimimetics |
10/23/2008 | US20080261924 Administering a bisphosphonate; risedronate, ibandronate, pamidronate, alendronate, cimadronate, tiludronate; osteoporosis |
10/23/2008 | US20080261910 Diagnostic Methods Based on Polymorphisms of Glucosyltransferase-Like Protein |
10/23/2008 | US20080261877 Albumin Fusion Proteins |
10/23/2008 | US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof |
10/23/2008 | US20080260862 Composition for treatment and prevention of bone loss |
10/23/2008 | US20080260831 useful as cell growth scaffolds; molded prior to implantation or administered to patient in an ungelled form prior to gelation where the composition gels in situ |
10/23/2008 | US20080260827 Continuous dosing schedule of one, two, or three consecutive days per month for osteoporosis, other bone disorders; patient compliance |
10/23/2008 | US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification |
10/23/2008 | US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta) |
10/23/2008 | US20080260799 Controlled long term release of regeneration stimulants and healing agents to surrounding tissues; artificial joints, stents, dental restoratives |
10/23/2008 | US20080260792 Method to Use Therapeutic Microencapsulation of Embedding Parathyroid Live Cells with Theracyte |
10/23/2008 | US20080260752 Prevention and reduction of blood loss |
10/23/2008 | US20080260727 Modulation of Nkg2d |
10/23/2008 | US20080260714 Nutrient mixture comprising fibrin, thrombin and a strontium-containing compound for use as therapeutic in bone healing or bone growth |
10/23/2008 | US20080260712 Apparatus which enhances stability of invertebrate discs by reducing bending hysteresis of scoliotic spines; improving resistance of collagenous tissue to mechanical degradation |
10/23/2008 | US20080260703 Using pancreatic stem cell culture to control insulin responsiveness; tissue engineering; regenerative medicine |
10/23/2008 | CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect |
10/23/2008 | CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes |
10/23/2008 | CA2682391A1 (aza)indole derivative and use thereof for medical purposes |
10/22/2008 | EP1983055A1 Albumin fusion proteins |
10/22/2008 | EP1982990A1 Cytokine receptor common gamma chain like |
10/22/2008 | EP1982981A1 Process for production of lasofoxifene or analogue thereof |